Rowena Albanna serves as Executive at ADiTx Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Rowena Albanna has executed 9 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 4, 2021 involved receiving (via award) 75,000 shares valued at $0.
Rowena Albanna currently holds 826,620 shares of ADiTx Therapeutics, Inc. (ADTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rowena Albanna has been a net buyer of ADTX stock. They have purchased $10.0K and sold $0 worth of shares.
Rowena Albanna's most recent insider trade was on Jun 4, 2021, when they sold 75,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.90 |
| Discretionary |
| Jun 1, 2021 | ADTX | $1.5K | Purchase | 500 | $2.93 | Discretionary |
| Jun 1, 2021 | ADTX | $3.0K | Purchase | 1,000 | $2.95 | Discretionary |
| Jun 1, 2021 | ADTX | $3.0K | Purchase | 1,000 | $2.95 | Discretionary |
| Jun 1, 2021 | ADTX | $289 | Purchase | 100 | $2.89 | Discretionary |
| Feb 24, 2021 | ADTX | $0 | Award | 225,000 | $N/A | Discretionary |
| Jul 24, 2020 | ADTX | $428.1K | Exercise | 38,055 | $11.25 | Discretionary |
| Jul 24, 2020 | ADTX | $400.0K | Exercise | 35,555 | $11.25 | Discretionary |